CoChat

Regulatory T-Cell Response to Apolipoprotein B100–Derived Peptides Reduces the Development and Progression of Atherosclerosis in Mice

Herbin, Olivier, Ait-Oufella, Hafid, Yu, Wang, Fredrikson, Gunilla Nordin, Aubier, Benjamin, Perez, Nicolas, Barateau, Véronique, Nilsson, Jan, Tedgui, Alain, Mallat, Ziad · 2012 · Arteriosclerosis, Thrombosis, and Vascular Biology
Cited by 132

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Objective—: The immunoinflammatory response plays a critical role in the development and progression of atherosclerosis. Recent studies suggested an important role for regulatory T (Treg) cells in the inhibition of disease-related vascular inflammation. We hypothesized that induction of a specific Treg cell response to atherosclerosis-relevant antigens would be an attractive strategy to limit the development and progression of atherosclerosis through the promotion of immune tolerance. Methods and Results—: Young or old Apoe −/− mice were subcutaneously infused for 2 weeks with either a control ovalbumin (OVA) peptide or with apolipoprotein B100 (ApoB100)–derived peptides without adjuvant. Atherosclerosis development, progression and immunologic status were assessed at 8 weeks after the end of the infusion. Treatment with ApoB100 peptides led to significant reduction of lesion development in young Apoe −/− mice ( P =0.001 versus OVA group) and abrogated atherosclerosis progression in old Apoe −/− mice with already established lesions (0% progression in ApoB100 versus 17% in OVA group, P <0.005). Limitation of plaque progression was associated with reduced vascular inflammation and increased collagen content, indicative of plaque stabilization. Infusion of ApoB100 peptides did not alter antibody production but promoted a specific Treg cell response, which was associated with a reduction of both T helper type 1–related and T helper type 2–related cytokines. Interestingly, depletion of CD4 + CD25 + Treg cells abrogated ApoB100 peptides-dependent immune modulation and atheroprotection. Conclusion—: Subcutaneous infusion of adjuvant-free ApoB100-derived peptides to Apoe −/− mice reduces atherosclerosis through the induction of a specific Treg cell response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/atvbaha.111.242800

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 132

Metadata

Authors
Herbin, O., Ait-Oufella, H., Yu, W., Fredrikson, G. N., Aubier, B., Perez, N., Barateau, V., Nilsson, J., Tedgui, A., & Mallat, Z.
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
2012-03
Volume
32
Issue
3
Pages
605-612
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W2121090555
Cited by
132
References
1
FWCI
5.92
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Regulatory T-Cell Response to Apolipoprotein B100–Derived Peptides Reduces the Development and Progression of Atherosclerosis in Mice. https://app.cochat.ai/papers/10.1161/atvbaha.111.242800
The paper
Herbin, O., Ait-Oufella, H., Yu, W., Fredrikson, G. N., Aubier, B., Perez, N., Barateau, V., Nilsson, J., Tedgui, A., & Mallat, Z. (2012). Regulatory T-Cell Response to Apolipoprotein B100–Derived Peptides Reduces the Development and Progression of Atherosclerosis in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.111.242800

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.